DocWire News Editors

DocwireNews

Guidelines from the World Health Organization and National Comprehensive Cancer Network recommend that all patients with diffuse large B-cell lymphoma (DLBCL) receive immunohistochemistry (IHC) as a surrogate of gene expression profiling to identify cell of origin and molecular testing by fluorescence in situ hybridization or karyotype to identify molecular/cytogenetic features. However, a study presented at the 2020 ASH Annual Meeting observed socioeconomic disparities related to the access to molecular testing for patients with DLBCL.This retrospective cohort study analyzed the Flatiron Health electronic health record (EHR)-derived deidentified database and identified 5,387 adults with a diagnosis of DLBCL between January 2011 and December 2019. They assessed the following socioeconomic determinants of health: age, gender, type of insurance plan, race/ethnicity, and geographic location of residency.The researchers observed that guideline-recommended diagnostic testing rates increased from 66.9% in 2011 to 85.6% in 2019 for IHC and from 49.5% to 67.0% for molecular testing (P&lt;0.001 for both).There was no association between any socioeconomic determinants and test utilization throughout the study period for IHC; however, patients who were older (odds ratio [OR], 0.97; 95% confidence interval [CI], 0.96-0.98), female (OR, 0.77; 95% CI, 0.64-0.93), living in the northeast (OR, 0.75; 95% CI, 0.58-0.97), and uninsured (OR, 0.65; 95% CI, 0.51-0.82) had lower odds of undergoing molecular testing.Compared with white patients, Asian patients were more likely to have molecular testing (OR, 4.06; 95% CI, 1.81-10.84); no association was found for other racial/ethnic groups.&ldquo;Providing equitable access to diagnostic testing would be a critical parameter for patients&rsquo; clinical benefit,&rdquo; the researchers concluded.ReferenceYang F, Abraham A, Zhang J, et al. Socioeconomic Disparities in Diagnostic Testing Among Patients with Diffuse Large B-Cell Lymphoma in the US. Abstract 2502. Presented at the 62nd American Society of Hematology Annual Meeting &amp; Exposition, December 2-11, 2020.

Bradley Marder, MD

Joel M. Topf, MD, FACP

Gout Studies: Transplant Waitlisting and Bone Erosion

NKF Spring Clinical Meetings 2025

Jayme Locke, MD, MPH

The Promise of Xenotransplantation

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Latest News

Socioeconomic Disparities Impact Access to Care for Patients with DLBCL

ASH Annual Meeting 2020

Guidelines from the World Health Organization and National Comprehensive Cancer Network recommend that all patients with diffuse large B-cell lymphoma (DLBCL) receive ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe